Motilal Oswal sees 28% upside in Glenmark Pharma, hails $700 mln cancer drug deal as ‘new era’ for innovation play
Motilal Oswal has reiterated a “buy” rating on Glenmark Pharmaceuticals with a raised target price of Rs 2,430, implying a ...
Tag: Glenmark Pharma
Stocks to buy or sell today: GMDC, CDSL among top 7 trading ideas for 9 November 2023
Indian market is expected to open higher on Thursday tracking positive global cues. The S&P BSE Sensex and Nifty50 closed ...
Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr
Glenmark Pharmaceuticals to sell 75% stake in Glenmark Life Sciences to Nirma for Rs 5,652 cr - The Economic Times ...
